Mold Linked to Asthma in Children

Published Online: Monday, November 12, 2012
Follow Pharmacy_Times:
A recent substudy of the Cincinnati Childhood Allergy and Air Pollution Study linked 3 specific mold species with the development of childhood asthma.

The study, which was published in the September 2012 edition of the Journal of Allergy and Clinical Immunology, looked at 8-month-old infants born between 2001 and 2003 in Cincinnati, Ohio, and northern Kentucky. Researchers collected dust samples from 289 homes. The samples were analyzed for 36 molds that comprise the Environmental Relative Moldiness Index (ERMI), as well as other factors such as endotoxin, house dust mites, and cat and dog allergens.

At 1 year of age, researchers evaluated the infants’ family asthma history as well as other environmental, home, and family factors, such as exposure to cigarette smoke and the age of the home. At 7 years of age, researchers examined the children for asthma; 24% were diagnosed with the condition. Researchers found that high ERMI values in the child’s home in infancy significantly increased the risk of asthma.

The researchers identified 3 specific molds common to water-damaged buildings, Aspergillus ochraceus, Aspergillus unguis, and Penicillium variabile, that were significantly connected with childhood development of asthma. The study also identified parental asthma, low income, and upper respiratory tract infections at 1 year of age to be strong risk factors for asthma.


Related Articles
Alpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients’ treatment preferences when chronic disease is present.
Elite Pharmaceuticals has launched a generic version of Atarax and Vistaril in 3 tablet strengths.
AstraZeneca and Abbott are teaming up to develop companion diagnostic blood tests that will identify patients with severe asthma who would benefit most from biological tralokinumab therapy.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$